These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 25300552)
1. Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs. Garbuzenko OB; Winkler J; Tomassone MS; Minko T Langmuir; 2014 Nov; 30(43):12941-9. PubMed ID: 25300552 [TBL] [Abstract][Full Text] [Related]
2. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone. Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436 [TBL] [Abstract][Full Text] [Related]
3. Development of l-Amino-Acid-Based Hydroxyl Functionalized Biodegradable Amphiphilic Polyesters and Their Drug Delivery Capabilities to Cancer Cells. Saxena S; Jayakannan M Biomacromolecules; 2020 Jan; 21(1):171-187. PubMed ID: 31592651 [TBL] [Abstract][Full Text] [Related]
4. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines. Doktorovova S; Souto EB; Silva AM Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267 [TBL] [Abstract][Full Text] [Related]
5. Intracellularly Degradable, Self-Assembled Amphiphilic Block Copolycurcumin Nanoparticles for Efficient In Vivo Cancer Chemotherapy. Lv L; Guo Y; Shen Y; Liu J; Zhang W; Zhou D; Guo S Adv Healthc Mater; 2015 Jul; 4(10):1496-501, 1423. PubMed ID: 26033838 [TBL] [Abstract][Full Text] [Related]
6. The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin. Kolter M; Wittmann M; Köll-Weber M; Süss R Eur J Pharm Biopharm; 2019 Jul; 140():20-28. PubMed ID: 31015019 [TBL] [Abstract][Full Text] [Related]
7. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery. Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360 [TBL] [Abstract][Full Text] [Related]
8. Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells. Liu Q; Zhang J; Sun W; Xie QR; Xia W; Gu H Int J Nanomedicine; 2012; 7():999-1013. PubMed ID: 22403484 [TBL] [Abstract][Full Text] [Related]
9. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy. Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729 [TBL] [Abstract][Full Text] [Related]
10. PEG-coumarin nanoaggregates as π-π stacking derived small molecule lipophile containing self-assemblies for anti-tumour drug delivery. Behl G; Kumar P; Sikka M; Fitzhenry L; Chhikara A J Biomater Sci Polym Ed; 2018 Mar; 29(4):360-375. PubMed ID: 29271302 [TBL] [Abstract][Full Text] [Related]
11. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells. Huang WT; Larsson M; Lee YC; Liu DM; Chiou GY Eur J Pharm Biopharm; 2016 Dec; 109():165-173. PubMed ID: 27793756 [TBL] [Abstract][Full Text] [Related]
12. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer. Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703 [TBL] [Abstract][Full Text] [Related]
13. Novel dipeptide nanoparticles for effective curcumin delivery. Alam S; Panda JJ; Chauhan VS Int J Nanomedicine; 2012; 7():4207-22. PubMed ID: 22915849 [TBL] [Abstract][Full Text] [Related]
14. Dual Functional Nanocarrier for Cellular Imaging and Drug Delivery in Cancer Cells Based on π-Conjugated Core and Biodegradable Polymer Arms. Kulkarni B; Surnar B; Jayakannan M Biomacromolecules; 2016 Mar; 17(3):1004-16. PubMed ID: 26842888 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue. Gawde KA; Kesharwani P; Sau S; Sarkar FH; Padhye S; Kashaw SK; Iyer AK J Colloid Interface Sci; 2017 Jun; 496():290-299. PubMed ID: 28236692 [TBL] [Abstract][Full Text] [Related]
16. Albumin nanoparticles with synergistic antitumor efficacy against metastatic lung cancers. Kim B; Seo B; Park S; Lee C; Kim JO; Oh KT; Lee ES; Choi HG; Youn YS Colloids Surf B Biointerfaces; 2017 Oct; 158():157-166. PubMed ID: 28688365 [TBL] [Abstract][Full Text] [Related]
17. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors. Jiang H; Geng D; Liu H; Li Z; Cao J Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102 [TBL] [Abstract][Full Text] [Related]
18. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer. Li C; Ge X; Wang L Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539 [TBL] [Abstract][Full Text] [Related]
19. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. Ranjan AP; Mukerjee A; Helson L; Vishwanatha JK J Nanobiotechnology; 2012 Aug; 10():38. PubMed ID: 22937885 [TBL] [Abstract][Full Text] [Related]
20. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system. Wang L; Wang W; Rui Z; Zhou D Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]